1. Zhang, Yunkai, Gao, Ying, Wang, Yujia, Zhan, Zhenzhen, Liu, Xingguang. 2024. RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring. In Cellular & molecular immunology, 21, 1231-1250. doi:10.1038/s41423-024-01212-3. https://pubmed.ncbi.nlm.nih.gov/39251781/
2. Le Sénéchal, Ronan, Keruzoré, Marc, Quillévéré, Alicia, Granzhan, Anton, Blondel, Marc. . Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA. In Nucleic acids research, 51, 11239-11257. doi:10.1093/nar/gkad772. https://pubmed.ncbi.nlm.nih.gov/37811881/
3. Zhi, Lili, Chen, Chaoqun, Zhang, Ge, Zhang, Wenjing, Wang, Yang. 2024. RBM25 depletion suppresses the growth of colon cancer cells through regulating alternative splicing of MNK2. In Science China. Life sciences, 67, 2186-2197. doi:10.1007/s11427-023-2582-x. https://pubmed.ncbi.nlm.nih.gov/39110401/
4. Tian, Xin, Zhou, Guangli, Li, Hao, Liu, Chen, Yang, Ping. 2023. RBM25 binds to and regulates alternative splicing levels of Slc38a9, Csf1, and Coro6 to affect immune and inflammatory processes in H9c2 cells. In PeerJ, 11, e16312. doi:10.7717/peerj.16312. https://pubmed.ncbi.nlm.nih.gov/37953772/
智鼠故事 
